Plan France Médecine Génomique 2025
Overview
Plan France Médecine Génomique 2025 is a biotechnology company headquartered in Paris, France, founded in 2015, with approximately 5,001 employees.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Plan France Médecine Génomique 2025 in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.